Recently, a strategy targeting the epidermal growth factor receptor (EGFR), which is overexpressed and contributes to the aggressive behavior of oral cancer, has shown beneficial results, particularly in advanced or recurrent cases where other therapies are no longer effective [4]. This evidence concerns the gene EGFR and lip and oral cavity carcinoma.